GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ibnsina Pharma (CAI:ISPH) » Definitions » Additional Paid-In Capital

Ibnsina Pharma (CAI:ISPH) Additional Paid-In Capital : E£237 Mil(As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Ibnsina Pharma Additional Paid-In Capital?


Ibnsina Pharma's quarterly additional paid-in capital increased from Sep. 2023 (E£235 Mil) to Dec. 2023 (E£237 Mil) but then stayed the same from Dec. 2023 (E£237 Mil) to Mar. 2024 (E£237 Mil).

Ibnsina Pharma's annual additional paid-in capital increased from Dec. 2021 (E£0 Mil) to Dec. 2022 (E£278 Mil) but then declined from Dec. 2022 (E£278 Mil) to Dec. 2023 (E£237 Mil).

Ibnsina Pharma Additional Paid-In Capital Historical Data

The historical data trend for Ibnsina Pharma's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ibnsina Pharma Additional Paid-In Capital Chart

Ibnsina Pharma Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only - - - 277.50 237.41

Ibnsina Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 277.50 235.00 237.41 237.41

Ibnsina Pharma Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Ibnsina Pharma Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Ibnsina Pharma's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Ibnsina Pharma (CAI:ISPH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ibnsina Pharma (CAI:ISPH) » Definitions » Additional Paid-In Capital
Comparable Companies
TSE:3945 TSE:6342 TSE:3877 TSE:3892 TSE:3513 TSE:3955 TSE:3878 NGO:3952 TSE:3896 TSE:7426 MCK COR CAH HSIC SHSE:601607 HKSE:01099 MIL:AMP NZSE:EBO XSWX:GALE TSE:7459
Traded in Other Exchanges
N/A
Address
Industrial zone 1, PO box 91, Obour, EGY
Website
http://www.ibnsina-pharma.com
Ibnsina Pharma is an Egypt based pharmaceutical distribution company. It is engaged in purchasing and selling in wholesale and distribution of pharmaceutical, semi- pharmaceutical and cosmetic products. It distributes a portfolio of pharmaceutical products from local and multinational pharmaceutical companies to retail pharmacies, wholesalers, hospitals, and public health institutions. In addition, the company also offers services including warehousing and logistics, marketing solutions, importation, and packaging, market research, and analysis.

Ibnsina Pharma (CAI:ISPH) Headlines

No Headlines